Rett Syndrome Completed Phase 1 Trials for L-Acetylleucine (DB16956)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01253317Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)Treatment